REFERENCES
1. GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1923-94.
2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021;398:957-80.
3. Booth J. A short history of blood pressure measurement. Available from:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1543468/pdf/procrsmed00089-0065.pdf [Last accessed on 10 May 2023].
4. Rabi DM, McBrien KA, Sapir-Pichhadze R, et al. Hypertension Canada's 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children. Can J Cardiol 2020;36:596-624.
5. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of Cardiology/American heart association task force on clinical practice guidelines. Hypertension 2018;71:1269-324.
6. Stergiou GS, Palatini P, Parati G, et al; European society of hypertension council and the European society of hypertension working group on blood pressure monitoring and cardiovascular variability. 2021 European society of hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens 2021;39:1293-302.
7. Unger T, Borghi C, Charchar F, et al. 2020 international society of hypertension global hypertension practice guidelines. Hypertension 2020;75:1334-57.
8. Padwal R, Campbell NRC, Schutte AE, et al. Optimizing observer performance of clinic blood pressure measurement: a position statement from the lancet commission on hypertension group. J Hypertens 2019;37:1737-45.
10. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure and mortality: a population-based study. Hypertension 2005;45:499-504.
11. Muntner P, Shimbo D, Carey RM, et al. Measurement of blood pressure in humans: a scientific statement from the american heart association. Hypertension 2019;73:e35-66.
12. Verdecchia P, Reboldi GP, Angeli F, et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension 2005;45:203-8.
13. Schwartz JE, Muntner P, Kronish IM, et al. Reliability of office, home, and ambulatory blood pressure measurements and correlation with left ventricular mass. J Am Coll Cardiol 2020;76:2911-22.
14. Schutte AE, Kollias A, Stergiou GS. Blood pressure and its variability: classic and novel measurement techniques. Nat Rev Cardiol 2022;19:643-54.
15. Jo SH, Kim SA, Park KH, Kim HS, Han SJ, Park WJ. Self-blood pressure monitoring is associated with improved awareness, adherence, and attainment of target blood pressure goals: prospective observational study of 7751 patients. J Clin Hypertens 2019;21:1298-304.
16. Shimbo D, Artinian NT, Basile JN, et al. American Heart Association and the American Medical Association. Self-measured blood pressure monitoring at home: a joint policy statement from the American heart association and American medical association. Circulation 2020;142:e42-63.
17. Sharman JE, Padwal R, Campbell NRC. Global marketing and sale of accurate cuff blood pressure measurement devices. Circulation 2020;142:321-3.
18. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
19. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J. Measurement of blood pressure in the office: recognizing the problem and proposing the solution. Hypertension 2010;55:195-200.
20. Rinfret F, Cloutier L, L'Archevêque H, et al. The gap between manual and automated office blood pressure measurements results at a hypertension clinic. Can J Cardiol 2017;33:653-7.
21. Stergiou GS, Asayama K, Thijs L, et al; International database on HOme blood pressure in relation to cardiovascular outcome (IDHOCO) Investigators. Prognosis of white-coat and masked hypertension: international database of HOme blood pressure in relation to cardiovascular outcome. Hypertension 2014;63:675-82.
22. Myers MG, Valdivieso M, Kiss A. Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens 2009;27:280-6.
23. Bauer F, Seibert FS, Rohn B, et al. Attended versus unattended blood pressure measurement in a real life setting. Hypertension 2018;71:243-9.
24. Ringrose JS, Cena J, Ip S, Morales F, Hamilton P, Padwal R. Comparability of automated office blood pressure to daytime 24-hour ambulatory blood pressure. Can J Cardiol 2018;34:61-5.
25. Drawz PE, Pajewski NM, Bates JT, et al. Effect of intensive versus standard clinic-based hypertension management on ambulatory blood pressure: results from the sprint (systolic blood pressure intervention trial) ambulatory blood pressure study. Hypertension 2017;69:42-50.
26. Bress AP, Cohen JB, Anstey DE, et al. Inequities in hypertension control in the United States exposed and exacerbated by COVID-19 and the role of home blood pressure and virtual health care during and after the COVID-19 pandemic. J Am Heart Assoc 2021;10:e020997.
27. Khan NA, Stergiou GS, Omboni S, et al. Virtual management of hypertension: lessons from the COVID-19 pandemic-international society of hypertension position paper endorsed by the world hypertension league and European society of hypertension. J Hypertens 2022;40:1435-48.
28. Donaghy E, Atherton H, Hammersley V, et al. Acceptability, benefits, and challenges of video consulting: a qualitative study in primary care. Br J Gen Pract 2019;69:e586-94.
29. Parati G, Dolan E, McManus RJ, Omboni S. Home blood pressure telemonitoring in the 21st century. J Clin Hypertens 2018;20:1128-32.
30. Omboni S, McManus RJ, Bosworth HB, et al. Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: an international expert position paper. Hypertension 2020;76:1368-83.
31. Margolis KL, Bergdall AR, Crain AL, et al. Comparing Pharmacist-led telehealth care and clinic-based care for uncontrolled high blood pressure: the hyperlink 3 pragmatic cluster-randomized trial. Hypertension 2022;79:2708-20.
32. Pletcher MJ, Fontil V, Modrow MF, et al. Effectiveness of standard vs enhanced self-measurement of blood pressure paired with a connected smartphone application: a randomized clinical trial. JAMA Intern Med 2022;182:1025-34.
33. Hammersley V, Parker R, Paterson M, et al. Telemonitoring at scale for hypertension in primary care: An implementation study. PLoS Med 2020;17:e1003124.
34. Kaambwa B, Bryan S, Jowett S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis. Eur J Prev Cardiol 2014;21:1517-30.
35. Monahan M, Jowett S, Nickless A, et al. Cost-Effectiveness of telemonitoring and self-monitoring of blood pressure for antihypertensive titration in primary care (TASMINH4). Hypertension 2019;73:1231-9.
36. Padwal R, McAlister FA, Wood PW, et al. Telemonitoring and Protocolized case management for hypertensive community-dwelling seniors with diabetes: protocol of the TECHNOMED randomized controlled trial. JMIR Res Protoc 2016;5:e107.
37. McManus RJ, Little P, Stuart B, et al. Home and online management and evaluation of blood pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial. BMJ 2021;372:m4858.
38. Stoddart A, Hanley J, Wild S, et al. Telemonitoring-based service redesign for the management of uncontrolled hypertension (HITS): cost and cost-effectiveness analysis of a randomised controlled trial. BMJ Open 2013;3:e002681.
39. Padwal RS, So H, Wood PW, et al. Cost-effectiveness of home blood pressure telemonitoring and case management in the secondary prevention of cerebrovascular disease in Canada. J Clin Hypertens 2019;21:159-68.
40. Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens 2013;31:455-67; discussion 467.
41. Duan Y, Xie Z, Dong F, et al. Effectiveness of home blood pressure telemonitoring: a systematic review and meta-analysis of randomised controlled studies. J Hum Hypertens 2017;31:427-37.
42. Padwal R, Wood PW. Digital health approaches for the assessment and optimisation of hypertension care provision. Can J Cardiol 2021;37:711-21.
43. Padwal RS, Wood PW, Ringrose JS. How a cloud based platform can make ambulatory blood pressure monitoring more efficient, accessible, and evidence based. Connected Health. 2022;1:36-45. Conn Health Telemed 2022;1:36-45.
44. Tomitani N, Kanegae H, Suzuki Y, Kuwabara M, Kario K. Stress-induced blood pressure elevation self-measured by a wearable watch-type device. Am J Hypertens 2021;34:377-82.
45. Goldberg EM, Levy PD. New approaches to evaluating and monitoring blood pressure. Curr Hypertens Rep 2016;18:49.
46. Mukkamala R, Stergiou GS, Avolio AP. Cuffless blood pressure measurement. Annu Rev Biomed Eng 2022;24:203-30.
47. Bradley CK, Shimbo D, Colburn DA, et al. Cuffless blood pressure devices. Am J Hypertens 2022;35:380-7.
48. Padwal R. Cuffless blood pressure measurement: how did accuracy become an afterthought? Am J Hypertens 2019;32:807-9.
49. Sola J, Vybornova A, Fallet S, Polychronopoulou E, Wurzner-Ghajarzadeh A, Wuerzner G. Validation of the optical Aktiia bracelet in different body positions for the persistent monitoring of blood pressure. Scientific Reports 2021;11:1-11.
50. Kario K, Harada N, Okura A. State-of-the-art rapid review of the current landscape of digital hypertension. Conn Health Telemed 2022;1:46-58.
51. Kario K, Harada N, Okura A. Digital therapeutics in hypertension: evidence and perspectives. Hypertension 2022;79:2148-58.
52. Available from: https://dtxalliance.org/understanding-dtx/what-is-a-dtx/ [Last accessed on 10 May 2023].
53. Guideline WHO. Recommendations on digital interventions for health system strengthening. Available from: https://www.who.int/publications/i/item/9789241550505 [Last accessed on 10 May 2023].
